Next Article in Journal
A Physician’s View of One Health: Challenges and Opportunities
Previous Article in Journal
Acknowledgement to Reviewers of Veterinary Sciences in 2014
Article Menu

Export Article

Open AccessCase Report
Vet. Sci. 2015, 2(1), 13-22; doi:10.3390/vetsci2010013

Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs

1
Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA
2
Department of Medical Sciences, School of Veterinary Medicine, 2015 Linden Drive West, University of Wisconsin, Madison, WI 53706, USA
*
Author to whom correspondence should be addressed.
Academic Editors: Duncan Ferguson and Margarethe Hoenig
Received: 30 December 2014 / Accepted: 2 February 2015 / Published: 5 February 2015
View Full-Text   |   Download PDF [2182 KB, uploaded 5 February 2015]   |  

Abstract

Gingival overgrowth is an uncommon adverse effect of cyclosporine administration in veterinary species. In people, gingival overgrowth is a common complication of cyclosporine administration for immunosuppression, generally following transplant procedures. Azithromycin has been used successfully for managing gingival overgrowth in human transplant patients when cyclosporine administration cannot be reduced or discontinued. This case series describes six dogs being administered cyclosporine for various dermatologic diseases that developed gingival overgrowth. The dogs were prescribed systemic azithromycin, with or without concurrent dose reduction of cyclosporine. Oral administration of 6.6–10.8 mg/kg of azithromycin once daily for 4–14 weeks was effective for complete clinical resolution of gingival overgrowth. In most cases, gingival overgrowth did not recur even with continued cyclosporine administration long-term. Adverse events of long-term azithromycin administration did not occur in any of the dogs. This series highlights a potentially beneficial medical treatment option for gingival overgrowth even when cyclosporine dose reduction is not possible or elected, without the need for surgical resection of proliferative gingival tissue. View Full-Text
Keywords: cyclosporine; gingival overgrowth; azithromycin; dog cyclosporine; gingival overgrowth; azithromycin; dog
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Diesel, A.; Moriello, K. Medical Management of Cyclosporine-Induced Gingival Overgrowth Using Oral Azithromycin in Six Dogs. Vet. Sci. 2015, 2, 13-22.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vet. Sci. EISSN 2306-7381 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top